Evidence suggesting the role of specific genetic factors in cigarette smoking

Health Psychology

Volumn 18, Issue 1, 1999, Pages 14-20

  Lerman, Caryn ^c   Audrain, Janet ^d   Main, David ^d   Boyd, Neal R ^b   Caporaso, Neil E ^a   Bowman, Elise D ^a   Lockshin, Benjamin ^a   Shields, Peter G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d NONE

Author keywords

Dopamine; Genetics; Smoking

Indexed keywords

DNA; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; NICOTINE; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; SMOKING CESSATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE OF ONSET; AGED; ALLELES; CARRIER PROTEINS; CASE-CONTROL STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; RECEPTORS, DOPAMINE D2; SMOKING; SMOKING CESSATION; STATISTICS;

EID: 0032930292     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/0278-6133.18.1.14     Document Type: Article

References (35)

1. Bannon, M. J., Granneman, J. G., & Kapatos, G. (1995). The dopamine transporter: Potential involvement in neuropsychiatric disorders. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 179-188). New York: Raven Press.
2. 2 receptor gene in alcoholism. Journal of the American Medical Association, 263, 2055-2060.
3. Bolos, A. M., Dean, M., Lucas-Derse, S., Ramsburg, M., Brown, G. L., & Goldman, D. (1990). Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. Journal of the American Medical Association, 264, 3156-3160.
4. Carmelli, D., Swan, G. E., Robinette, D., & Fabsitz, R. (1992). Genetic influence on smoking - A study of male twins. New England Journal of Medicine, 327, 829-833.
5. Carr, L. A., Basham, J. K., York, B. K., & Rowell, P. P. (1992). Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components. European Journal of Pharmacology, 215, 285-287.
6. Centers for Disease Control. (1996). Cigarette smoking among adults - United States, 1994. Morbidity and Mortality Weekly Report, 45, 588-590.
7. Comings, D. E., Ferry, L., Bradshaw-Robinson, S., Burchette, R., Chiu, C., & Muhleman, D. (1996). The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics, 6, 73-79.
8. Comings, D. E., Wu, S., Chiu, C., Ring, R. H., Gade, R., Ahn, C., MacMurray, J. P., Dietz, G., & Muhleman, D. (1996). Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes -DRD2, D beta H, and DAT1. American Journal of Medical Genetics, 67, 264-288.
9. Cook, E. H., Jr., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., & Leventhal, B. L. (1995). Association of attention-deficit disorder and the dopamine transporter gene. American Journal of Human Genetics, 56, 993-998.
10. Dani, J. A., & Heinemann, S. (1996). Molecular and cellular aspects of nicotine abuse. Neuron, 16, 905-908.
11. Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences, USA, 85, 5274-5278.
12. Doucette-Stamm, L. A., Blakely, D. J., Tian, J., Mockus, S., & Mao, J. I. (1995). Population genetic study of the human dopamine transporter gene (DAT1). Genetic Epidemiology, 12, 303-308.
13. Ferry, L. H., Robbins, A. S., Scariati, P. D., Burchette, R. J., Masterson, G. A., & Abbey, D. E. (1992). Enhancement of smoking cessation using the anti-depressant bupropion hydrochloride [Abstract]. Circulation, 86, 671.
14. Gelernter, J., Goldman, D., & Risch, N. (1993). The A1 allele at the D2 dopamine receptor gene and alcoholism: A reappraisal. Journal of the American Medical Association, 269, 1673-1677.
15. Gelernter, J., Kranzler, H. R., Satel, S. L., & Rao, P. A. (1994). Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology, 11, 195-200.
16. Goldman, D., Brown, G. L., Albaugh, B., Robin, R., Goodson, S., Trunzo, M., Akhtar, L., Wynne, D. K., Lucas-Derse, S., Bolos, A. M., Tokola, R., Virkkunen, M., Linnoila, M., & Dean, M. (1994). D2 receptor genotype and linkage disequilibrium and function in Finnish, American Indian, and U. S. Caucasian patients. In E. S. Gershon & C. R. Cloninger (Eds.), Genetic approaches to mental disorders (pp. 327-344). Washington, DC: American Psychiatric Press.
17. Heath, A. C., & Martin, N. G. (1993). Genetic models for the natural history of smoking: Evidence for a genetic influence on smoking persistence. Addictive Behaviors, 18, 19-34.
18. Heatherton, T. R, Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
19. Henningfield, J. E., Schuh, L. M., & Jarvik, M. E. (1995). Pathophysiology of tobacco dependence. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 1715-1730). New York: Raven Press.
20. Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., Croghan, I. T., & Sullivan, P. M. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine, 337, 1195-1202.
21. Lerman, C., Caporaso, N., Main, D., Audrain, J., Boyd, N. R., Bowman, E. D., & Shields, P. G. (1998). Depression and self-medication with nicotine: The modifying influence of the dopamine D4 receptor gene. Health Psychology, 17, 56-62.
22. Lerman, C., Gold, K., Audrain, J., Lin, T. H., Boyd, N. R., Orleans, C. T., Wilfond, B., Louben, G., & Caporaso, N. (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: Effects on smoking-related cognitions, emotions, and behavior change. Health Psychology, 16, 87-99.
23. Lerman, C., Shields, P. G., Main, D., Audrain, J., Roth, J., Boyd, N. R., & Caporaso, N. E. (1997). Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking. Pharmacogenetics, 7, 521-524.
24. Newhouse, P. A., & Hughes, J. R. (1991). The role of nicotine and nicotinic mechanisms in neuropsychiatric disease. British Journal of Addiction, 86, 521-526.
25. Noble, E. P., Blum, K., Ritchie, T., Montgomery, A., & Sheridan, P. J. (1991). Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Archives of General Psychiatry, 48, 648-654.
26. Noble, E. P., Noble, R. E., Ritchie, T., Syndulko, K., Bohlman, M. C., Noble, L. A., Zhang, Y., Sparkes, R. S., & Grandy, D. K. (1994). D2 dopamine receptor gene and obesity. International Journal of Eating Disorders, 15, 205-217.
27. O'Neill, M. F., Dourish, C. T., & Iversen, S. D. (1991). Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology, 104, 343-350.
28. Plomin, R. (1998). Using DNA in health psychology. Health Psychology, 17, 53-55.
29. Plomin, R., Owen, M. J., & McGuffin, P. (1994). The genetic basis of complex human behaviors. Science, 264, 1733-1739.
30. Pontieri, F. E., Tanda, G., Orzi, F., & Di Chiara, G. (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature, 382, 255-257.
31. Risch, N. (1990). Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genetic Epidemiology, 7, 3-16.
32. Sabol, S. Z., Nelson, M. L., Fisher, C., Gunzerath, L., Brody, C. L., Hu, S., Sirota, L. A., Marcus, S. E., Greenberg, B. D., Lucas, F. R. IV, Benjamin, J., Murphy, D. L., & Hamer, D. H. (1999). A genetic association for cigarette smoking behavior. Health Psychology, 18, 7-13.
33. Seeman, P., & Niznik, H. B. (1990). Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB Journal, 4, 2737-2744.
34. Vandenbergh, D. J., Persico, A. M., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W., & Uhl, G. R. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics, 14, 1104-1106.
35. Wise, R. A., & Rompre, P. P. (1989). Brain dopamine and reward. Annual Review of Psychology, 40, 191-225.